Helix BioPharma Corp. Reports Voting Results and Appointment of New Board Director

RICHMOND HILL, ON / ACCESSWIRE / January 28, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment

Related Keywords

Toronto ,Ontario ,Canada ,Richmond Hill ,Frank Michalargias ,Slawomir Majewski ,National Instrument ,Toronto Stock Exchange ,Company Board Of Directors ,Helix Biopharma Corp ,Helix Biopharma ,Disclosure Obligations ,Adam Uszpolewicz ,Prof Slawomir ,Chief Financial ,Helix ,Iopharma ,Orp ,Reports ,Voting ,Results ,Appointment ,Board ,Director ,